Abstract

Tertiary lymphoid structures (TLS) are lymph node-like immune cell clusters that emerge during chronic inflammation in non-lymphoid organs like the kidney, but their origin remains not well understood. Here we show, using conditional deletion strategies of the canonical Notch signaling mediator Rbpj, that loss of endothelial Notch signaling in adult mice induces the spontaneous formation of bona fide TLS in the kidney, liver and lung, based on molecular, cellular and structural criteria. These TLS form in a stereotypical manner around parenchymal arteries, while secondary lymphoid structures remained largely unchanged. This effect is mediated by endothelium of blood vessels, but not lymphatics, since a lymphatic endothelial-specific targeting strategy did not result in TLS formation, and involves loss of arterial specification and concomitant acquisition of a high endothelial cell phenotype, as shown by transcriptional analysis of kidney endothelial cells. This indicates a so far unrecognized role for vascular endothelial cells and Notch signaling in TLS initiation.

Loss of canonical Notch signaling in vascular endothelial cells induces spontaneous formation of proto-typical tertiary lymphoid structures in mouse kidney, liver and lungs, which form around central arteries that acquire a high endothelial cell signature

Details

Title
Loss of vascular endothelial notch signaling promotes spontaneous formation of tertiary lymphoid structures
Author
Fleig, Susanne 1   VIAFID ORCID Logo  ; Kapanadze Tamar 2 ; Bernier-Latmani Jeremiah 3 ; Lill, Julia K 4 ; Wyss, Tania 5   VIAFID ORCID Logo  ; Jaba, Gamrekelashvili 2   VIAFID ORCID Logo  ; Kijas Dustin 2 ; Liu, Bin 6   VIAFID ORCID Logo  ; Hüsing, Anne M 7   VIAFID ORCID Logo  ; Bovay Esther 8 ; Jirmo Adan Chari 9   VIAFID ORCID Logo  ; Halle, Stephan 10   VIAFID ORCID Logo  ; Ricke-Hoch, Melanie 11   VIAFID ORCID Logo  ; Adams, Ralf H 8   VIAFID ORCID Logo  ; Engel, Daniel R 4   VIAFID ORCID Logo  ; von Vietinghoff Sibylle 12 ; Förster Reinhold 10   VIAFID ORCID Logo  ; Hilfiker-Kleiner Denise 13 ; Haller, Hermann 7 ; Petrova, Tatiana V 3   VIAFID ORCID Logo  ; Limbourg, Florian P 2   VIAFID ORCID Logo 

 Hannover Medical School, Vascular Medicine Research, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); Hannover Medical School, Department of Nephrology and Hypertension, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); RWTH Aachen University Hospital, Department of Geriatric Medicine (Medical Clinic VI), Aachen, Germany (GRID:grid.412301.5) (ISNI:0000 0000 8653 1507) 
 Hannover Medical School, Vascular Medicine Research, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); Hannover Medical School, Department of Nephrology and Hypertension, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
 Department of Oncology UNIL CHUV and Ludwig Institute for Cancer Research, Vascular and Tumor Biology Laboratory, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204) 
 University Hospital Essen, Department of Immunodynamics, Institute for Experimental Immunology and Imaging, Medical Research Centre, Essen, Germany (GRID:grid.410718.b) (ISNI:0000 0001 0262 7331) 
 Department of Oncology UNIL CHUV and Ludwig Institute for Cancer Research, Vascular and Tumor Biology Laboratory, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204); SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland (GRID:grid.419765.8) (ISNI:0000 0001 2223 3006) 
 Member of the German Center for Lung Research (DZL), Hannover Medical School, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Hannover, Germany (GRID:grid.452624.3) 
 Hannover Medical School, Department of Nephrology and Hypertension, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
 Max-Planck-Institute for Molecular Biomedicine, Muenster, Germany (GRID:grid.461801.a) (ISNI:0000 0004 0491 9305) 
 Member of the German Center for Lung Research (DZL), Hannover Medical School, Biomedical Research in Endstage and Obstructive Lung Disease (BREATH), Hannover, Germany (GRID:grid.452624.3); Hannover Medical School, Department of Pediatric Pneumology, Allergology and Neonatology, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
10  Hannover Medical School, Institute of Immunology, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
11  Hannover Medical School, Department of Cardiology and Angiology, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877) 
12  Hannover Medical School, Department of Nephrology and Hypertension, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); UKB Bonn University Hospital, Division of Medicine I, Nephrology section, Bonn, Germany (GRID:grid.411097.a) (ISNI:0000 0000 8852 305X) 
13  Hannover Medical School, Department of Cardiology and Angiology, Hannover, Germany (GRID:grid.10423.34) (ISNI:0000 0000 9529 9877); Medical Faculty of the Philipps University Marburg, Department of Cardiovascular Complications of Oncologic Therapies, Marburg, Germany (GRID:grid.10253.35) (ISNI:0000 0004 1936 9756) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2652408516
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.